Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 29, 2021 - Novartis announced the FDA approval of Scemblix (asciminib).
Download PDF
Return to publications
